Drug Information for IMITREX (sumatriptan succinate) InjectionFor Subcutaneous Use Only. (GlaxoSmithKline LLC): HOW SUPPLIED

Ads
  • IMITREX Injection contains sumatriptan (base) as the succinate salt and is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as follows:

    (NDC 0173-0739-00) IMITREX STATdose System®, 4 mg, containing 2 prefilled single-dose syringe cartridges, 1 IMITREX STATdose Pen®, 1 carrying case, and a patient information leaflet with instructions for use.

    (NDC 0173-0739-02) Two 4-mg single-dose prefilled syringe cartridges for use with IMITREX STATdose System with a patient information leaflet with instructions for use.

    (NDC 0173-0479-00) IMITREX STATdose System, 6 mg, containing 2 prefilled single-dose syringe cartridges, 1 IMITREX STATdose Pen, 1 carrying case, and a patient information leaflet with instructions for use.

    (NDC 0173-0478-00) Two 6-mg single-dose prefilled syringe cartridges for use with IMITREX STATdose System with a patient information leaflet with instructions for use.

    (NDC 0173-0449-02) IMITREX Injection single-dose vial (6 mg/0.5 mL) in cartons containing 5 vials.

    Store between 2° and 30°C (36° and 86°F). Protect from light.

    IMITREX, IMITREX STATdose System, and IMITREX STATdose Pen are registered trademarks of GlaxoSmithKline.

    This product's prescribing information may have been updated. Please refer to ww.gsk.com for the most current version.

    GlaxoSmithKline

    Research Triangle Park, NC 27709

    ©2010, GlaxoSmithKline. All rights reserved.

    February 2010

    IMJ:3PI

  • Drug Information Provided by National Library of Medicine (NLM).
Ads